COO Nov 2024 390.000 call
| Previous Close | 38.70 |
| Open | 38.70 |
| Bid | 28.70 |
| Ask | 34.40 |
| Strike | 390.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 38.70 - 38.70 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 4 |
ZacksAspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
Aspira (AWH) delivered earnings and revenue surprises of -8.33% and 2.52%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireCooperCompanies to Participate in the William Blair Growth Stock Conference
SAN RAMON, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled at 11:00 AM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. About C
ZacksReasons to Add The Cooper Companies (COO) to Your Portfolio
The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.
